A striking common O-linked N-acetylglucosaminyl moiety between cruzipain and myosin

Parasite Immunology

Volumn 33, Issue 7, 2011, Pages 363-370

  Acosta, D M ^a   Soprano, L L ^a   Ferrero, M ^a   Landoni, M ^b   Esteva, M I ^a   Couto, A S ^b   Duschak, V G ^a  

^a Ministerio de Salud de la Nación ^*  (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Chagas disease; Cruzipain; Myosin; O N acetyl d glucosamine; Trypanosoma cruzi

Indexed keywords

APROTININ; CRUZIPAIN; EPITOPE; MYOSIN; N ACETYLGLUCOSAMINE;

ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHAGAS DISEASE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; IMMUNOGOLD ELECTRON MICROSCOPY; MITOCHONDRION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ACETYLGLUCOSAMINE; ANIMALS; ANTIBODIES, PROTOZOAN; CROSS REACTIONS; CYSTEINE ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; MICE; MICE, INBRED BALB C; MICROSCOPY, IMMUNOELECTRON; MYOCARDIUM; MYOSINS; RABBITS; TRYPANOSOMA CRUZI;

MUS; ORYCTOLAGUS CUNICULUS; TRYPANOSOMA CRUZI;

EID: 79959187136     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01291.x     Document Type: Article

References (37)

1. Estimación cuantitativa de la Enfermedad de Chagas en las Américas Organización Panamericana (OPS) de la Salud. Ref type Pamphlet. Geneva, Pan American Health Organization/World Health Organization, 525 23rd Street, NW Washington, DC 20037, USA. Department of Control of Neglected Tropical Diseases (NTD). OPS/HDM/CD/-2006; 425.
2. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007; 102(Suppl. I): 75-85.
3. Gascon J, Bern C & Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010; 115: 22-27. Review.
4. Pan American Health Organization. Panamerican Health Organization Status of Chagas Disease in the Region of Americas. Epidemiologic Bulletin. Washington, DC, Pan American Health Organization, 1984.
5. Leon JS & Engman DM. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front Biosci 2003; 8: 315-322.
6. Tarleton RL. Parasite persistence in the etiology of Chagas disease. Int J Parasitol 2001; 31: 550-554.
7. Duschak VG & Couto AS. Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr Med Chem 2009; 16: 3174-3202.
8. Duschak VG & Couto AS. Targets and patented drugs for chemotherapy of Chagas disease. In Atta-ur-Rahman FRS & Choudhary MI (eds): Frontiers in Anti-Infective Drug Discovery, Vol. 1, Chapter 18. Bentham Science, 2010: 323-408.
9. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G & Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630-3636.
10. Tibbetts RS, McCormick TS, Rowland EC, Miller SD & Engman DM. Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. J Immunol 1994; 152: 1493-1499.
11. Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N & Kalil J. Autoimmunity in Chagas disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein cross-reactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996; 98: 1709-1712.
12. Rizzo LV, Cunha-Neto E & Teixeira AR. Autoimmunity in Chagas disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun 1989; 57: 2640-2644.
13. Leon JS, Godsel LM, Wang K & Engman DM. Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect Immun 2001; 69: 5643-5649.
14. Motran CC, Fretes RE, Cerbán FM, Rivarola HW & Vottero de Cima E. Immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins induces long-term duration cross-reactive antibodies with heart functional and structural alterations in young and aged mice. Clin Immunol 2000; 97: 89-94.
15. Giordanengo L, Maldonado C, Rivarola HW, et al. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur J Immunol 2000; 30: 3181-3189.
16. Leon JS, Daniels MD, Toriello KM, Wang K & Engman DM. A cardiac myosin specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun 2004; 72: 3410-3417.
17. Acosta DM, Arnaiz MR, Esteva MI, et al. Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice. Int Immunol 2008; 20: 461-470.
18. Vosseller K, Wells L, Lane MD & Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 2002; 99: 5313-5318.
19. Wells L & Hart GW. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett 2003; 546: 154-158. Review.
20. 2+ activation properties of rat skeletal muscle. J Biol Chem 2007; 282: 10360-10369.
21. Comer FI & Hart GW. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem 2000; 275: 29179-29182. Review
22. Arnold CS, Johnson GV, Cole RN, Dong DL, Lee M & Hart GW. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem 1996; 271: 28741-28744.
23. Yao PJ & Coleman PD. Reduction of O-linked N-acetylglucosamine modified assembly protein-3 in Alzheimer's disease. J Neurosci 1998; 18: 2399-23411.
24. Slawson C, Pidala J & Potter R. Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta 2001; 1537: 147-157.
25. Chou TY, Hart GW & Dang CV. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 1995; 270: 18961-18965.
26. Juang YT, Solomou EE, Rellahan B & Tsokos GC. Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain. J Immunol 2002; 168: 2865-2871.
27. Wang Z, Park K, Comer F, Hsieh-Wilson LC, Saudek CD & Hart GW. Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Diabetes 2009; 58: 309-317.
28. Pette D. Historical perspectives: plasticity of mammalian skeletal muscle. J Appl Physiol 2001; 90: 1119-1124.
29. Cieniewski-Bernard C, Bastide B, Lefebvre T, Lemoine J, Mounier Y & Michalski JC. Identification of O-linked N-acetylglucosamine proteins in rat skeletal muscle using two-dimensional gel electrophoresis and mass spectrometry. Mol Cell Proteomics 2004; 3: 577-585.
30. Barboza M, Duschak VG, Cazzulo JJ, de Lederkremer RM & Couto AS. Presence of sialic acid in N-linked oligosaccharide chains and O-linked N-acetylglucosamine in cruzipain, the major cysteine proteinase of Trypanosoma cruzi. Mol Biochem Parasitol 2003; 126: 293-296.
31. Spinella S, Liegeard P & Honte Beyrie-joskowics M. Trypanosoma cruzi: predominance of Ig2a in nonspecific humoral response during experimental Chagas disease. Exp Parasitol 1992; 74: 46-56.
32. Van Parijs LV, Peterson DA & Abbas AK. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 1998; 8: 265-274.
33. Hu Y, Suarez J, Fricovsky E, et al. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem 2009; 284: 547-555.
34. Lori J, Albert MD, Robert D & Inmanm D. Molecular mimicry and autoimmunity mechanisms of disease. Franklin H & Epstein MD (eds): N Engl J Med 1999; 341: 2068-2074.
35. Zachara NE & Hart GW. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev 2002; 102: 431-438.
36. Cunningham MW. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci 2003; 8: 533-543.
37. Guilherme L, Kalil J & Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006; 39: 31-39. Review.